A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Constellation Pharmaceuticals
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Ohio State University Comprehensive Cancer Center
University Hospital, Angers
M.D. Anderson Cancer Center
Ottawa Hospital Research Institute
University Health Network, Toronto
Herlev Hospital
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Novartis
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Mayo Clinic
Italfarmaco
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Italfarmaco
Eli Lilly and Company
Wake Forest University Health Sciences
Eli Lilly and Company
OHSU Knight Cancer Institute
California Cancer Consortium
UNC Lineberger Comprehensive Cancer Center
Traws Pharma, Inc.
Wake Forest University Health Sciences
Eli Lilly and Company
Fred Hutchinson Cancer Center
Galena Biopharma, Inc.
Alliance for Clinical Trials in Oncology
Icahn School of Medicine at Mount Sinai
Yale University
Hospital Israelita Albert Einstein
Alliance for Clinical Trials in Oncology
Geron Corporation
Teva Branded Pharmaceutical Products R&D, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AOP Orphan Pharmaceuticals AG
National Cancer Institute (NCI)
Children's Oncology Group
Indiana University
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)